Author:
Luebker Stephen A.,Koepsell Scott A.
Reference62 articles.
1. Cancer statistics, 2018;Siegel;CA Cancer J Clin.,2018
2. The genomic landscape of cutaneous melanoma;Zhang;Pigment Cell Melanoma Res.,2016
3. Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma;Menzies;Clin Cancer Res.,2012
4. Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study;McArthur;Lancet Oncol.,2014
5. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet.,2012
Cited by
135 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献